Aortic involvement in giant cell arteritis: Current data

Joint Bone Spine

Volumn 78, Issue 3, 2011, Pages 246-251

  Bossert, Marie ^a,b   Prati, Clément ^a   Balblanc, Jean Charles ^b   Lohse, Anne ^b   Wendling, Daniel ^a  

^a CHU Minjoz and université de Franche Comté and boulevard Fleming ^*  (France)

^b Belfort Hospital   (France)

Author keywords

Aortitis; Giant cell arteritis; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

CORTICOSTEROID; MEPREDNISONE; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AORTA ARCH SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DISEASE ACTIVITY; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE REDUCTION; DRUG MEGADOSE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LONG TERM CARE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RELAPSE; RHEUMATIC POLYMYALGIA; RISK; SHORT SURVEY; THORACIC AORTA ANEURYSM; THORAX RADIOGRAPHY; VASCULITIS;

AORTA; AORTITIS; COMORBIDITY; DIAGNOSTIC IMAGING; EUROPE; FEMALE; GIANT CELL ARTERITIS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SEX FACTORS;

EID: 79955536255     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.09.013     Document Type: Short Survey

References (53)

1. Mukhtyar C., Guillevin L., Cid M.C., et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009, 68:318-323.
2. Marie I., Proux A., Duhaut P., et al. Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine (Baltimore) 2009, 88:182-192.
3. Klein R.G., Hunder G.G., Stanson A.W., et al. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975, 83:806-812.
4. Evans J.M., Bowles C.A., Bjornsson J., et al. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994, 37:1539-1547.
5. Nuenninghoff D.M., Hunder G.G., Christianson T.J., et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003, 48:3522-3531.
6. Gonzalez-Gay M.A., Garcia-Porrua C., Piñeiro A., et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 2004, 83:335-341.
7. Rojo-Leyva F., Ratliff N.B., Cosgrove D.M., et al. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000, 43:901-907.
8. Miller D.V., Isotalo P.A., Weyand C.M., et al. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 2006, 30:1150-1158.
9. Liang K.P., Chowdhary V.R., Michet C.J., et al. Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol 2009, 36:2290-2297.
10. Agard C., Barrier J.H., Dupas B., et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008, 59:670-676.
11. Hunder G.G., Bloch D.A., Michel B.A., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
12. Devauchelle-Pensec V., Jousse S., Destombe C., et al. Epidemiology, imaging, and treatment of giant cell arteritis. Joint Bone Spine 2008, 75:267-272.
13. Le Tourneau T., Millaire A., Asseman P., et al. Aortitis in Horton disease. Review of the literature. Ann Med Interne (Paris) 1996, 147:361-368.
14. Brack A., Martinez-Taboada V., Stanson A., et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999, 42:311-317.
15. Schmidt W.A., Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005, 17:9-15.
16. Duhaut P., Pinède L., Bornet H., et al. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Ann Rheum Dis 1999, 58:335-341.
17. Agard C., Said L., Ponge T., et al. Abdominal aortic involvement in active giant cell (temporal) arteritis: a study of 20 patients by Doppler ultrasonography and computed tomographic angiography. Presse Med 2009, 38:11-19.
18. Hervé F., Choussy V., Janvresse A., et al. Aortic involvement in giant cell arteritis. A prospective follow-up of 11 patients using computed tomography. Rev Med Interne 2006, 27:196-202.
19. Liozon E., Monteil J. Place de la tomographie par émission de positons (TEP) au 18F FDG dans l'exploration des vascularites. Med Nucleaire 2008, 32:511-522.
20. Walter M.A. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am 2007, 45:735-744.
21. Belhocine T., Blockmans D., Hustinx R., et al. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 2003, 30:1305-1313.
22. Blockmans D. The use of (18F)fluoro-deoxyglucose positron emission tomography in the assessment of large vessel vasculitis. Clin Exp Rheumatol 2003, 21:S15-S22.
23. Henes J.C., Müller M., Krieger J., et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 2008, 26:S47-S52.
24. Hautzel H., Sander O., Heinzel A., et al. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 2008, 49:1107-1113.
25. Blockmans D., de Ceuninck L., Vanderschueren S., et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006, 55:131-137.
26. Walter M.A., Melzer R.A., Schindler C., et al. The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005, 32:674-681.
27. Scheel A.K., Meller J., Vosshenrich R., et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 2004, 63:1507-1510.
28. de Leeuw K., Bijl M., Jager P.L. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 2004, 22:S21-S26.
29. Brodmann M., Lipp R.W., Passath A., et al. The role of 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology 2004, 43:241-242.
30. Bleeker-Rovers C.P., Bredie S.J., van der Meer J.W., et al. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth J Med 2003, 61:323-329.
31. Brodmann M., Passath A., Aigner R., et al. F18-FDG-PET as a helpful tool in the diagnosis of giant cell arteritis. Rheumatology (Oxford) 2003, 42:1264-1266.
32. Meller J., Strutz F., Siefker U., et al. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 2003, 30:730-736.
33. Blockmans D., Stroobants S., Maes A., et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000, 108:246-249.
34. Blockmans D., Maes A., Stroobants S., et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 1999, 38:444-447.
35. Pipitone N., Versari A., Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology 2008, 47:403-408.
36. Seo P., Stone J.H. Large-vessel vasculitis. Arthritis Rheum 2004, 51:128-139.
37. Meller J., Sahlmann C.O., Gürocak O., et al. FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q J Nucl Med Mol Imaging 2009, 53:51-63.
38. Narváez J., Narváez J.A., Nolla J.M., et al. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) 2005, 44:479-483.
39. Belhocine T., Kaye O., Delanaye P., et al. Horton's disease and extra-temporal vessel locations: role of 18FDG PET scan. Report of 3 cases and review of the literature. Rev Med Interne 2002, 23:584-591.
40. Both M., Ahmadi-Simab K., Reuter M., et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008, 67:1030-1033.
41. Cimmino M.A., Zampogna G., Parodi M. Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?. Rheumatology (Oxford) 2008, 47:926-927.
42. Mahr A.D., Jover J.A., Spiera R.F., et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007, 56:2789-2797.
43. Martínez-Taboada V.M., Rodríguez-Valverde V., Carreño L., et al. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 2000, 67:625-630.
44. Cantini F., Niccoli L., Salvarani C., et al. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum 2001, 44:2933-2935.
45. Evans J.M., O'Fallon W.M., Hunder G.G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995, 122:502-507.
46. Nuenninghoff D.M., Hunder G.G., Christianson T.J., et al. Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003, 48:3532-3537.
47. Pipitone N., Boiardi L., Bajocchi G., et al. Long-term outcome of giant cell arteritis. Clin Exp Rheumatol 2006, 24:S65-S70.
48. García-Martínez A., Hernández-Rodríguez J., Arguis P., et al. Development of aortic aneurysm/dilatation during the follow up of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008, 59:422-430.
49. Lie J.T. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995, 24:422-431.
50. Blockmans D., Coudyzer W., Vanderschueren S., et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008, 47:1179-1184.
51. Bongartz T., Matteson E.L. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 2006, 18:10-17.
52. Ytterberg S.R., Warrington K.J., Aletaha D., et al. Vasculitis Working Group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis. Joint Bone Spine 2009, 76:440-443.
53. Détaint D. Prise en charge thérapeutique des anévrysmes de l'aorte ascendante. AMC Pratique 2010, 185:15-21.